Clinical Trial Update: Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Early-phase study of CB-103 in adults with various advanced solid tumors and hematologic malignancies has been terminated; results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Breast Cancer
• Colorectal Cancer
• Glomus Tumor Malignant
• Hepatocellular Carcinoma
• Non-hodgkin Lymphoma
• Osteosarcoma
• T-all

Drugs mentioned

• CB-103

Snippet

Sponsor: Cellestia Biotech AG | Conditions: Breast Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-01-16